» Authors » Mattia Zampieri

Mattia Zampieri

Explore the profile of Mattia Zampieri including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 95
Citations 1236
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Argiro A, Biagioni G, Mazzoni C, Zampieri M, Allinovi M, Musumeci B, et al.
Int J Cardiol . 2025 Feb; 424:133027. PMID: 39900190
Background: Hypertension and diabetes may increase the risk of adverse events in the general population and patients with cardiomyopathies, however, their role in patients with cardiac amyloidosis (CA) is still...
2.
Schuhknecht L, Ortmayr K, Janes J, Blasi M, Panoussis E, Bors S, et al.
Nat Biotechnol . 2025 Jan; PMID: 39875672
Understanding a small molecule's mode of action (MoA) is essential to guide the selection, optimization and clinical development of lead compounds. In this study, we used high-throughput non-targeted metabolomics to...
3.
Porcari A, Razvi Y, Cappelli F, Nitsche C, Serenelli M, Longhi S, et al.
JAMA Cardiol . 2025 Jan; PMID: 39841451
Importance: Patients with transthyretin (ATTR) cardiac amyloid infiltration are increasingly diagnosed at earlier disease stages with no heart failure (HF) symptoms and a wide range of cardiac amyloid infiltration. Objective:...
4.
Argiro A, Zampieri M, Mazzoni C, Fumagalli C, Baccini M, Mattei A, et al.
ESC Heart Fail . 2024 Dec; PMID: 39665521
Aims: This study aimed to evaluate the change of the main electrocardiographic (ECG) characteristics and their prognostic role across the main subtypes of cardiac amyloidosis [light-chain amyloidosis (AL) and hereditary...
5.
Tini G, Musumeci B, Milani P, Zampieri M, Caponetti A, Fabris F, et al.
ESC Heart Fail . 2024 Sep; 12(1):379-388. PMID: 39301748
Aims: Disease staging and prognostic scoring in wild-type transthyretin-related cardiac amyloidosis (ATTRwt-CA) can be captured by two systems (NAC and Columbia scores). However, uncertainty remains as epidemiology of the disease...
6.
Tini G, Cristiano E, Zampieri M, Ponziani A, Porcari A, Zanoletti M, et al.
JACC Adv . 2024 Sep; 3(10):101232. PMID: 39290816
Background: The introduction of a noninvasive diagnostic algorithm in 2016 led to increased awareness and recognition of cardiac amyloidosis (CA). Objectives: The purpose of this study was to analyze the...
7.
Filali-Mouncef Y, Leytens A, Vargas Duarte P, Zampieri M, Dengjel J, Reggiori F
Autophagy . 2024 Jul; 20(10):2323-2337. PMID: 38958087
Autophagosome biogenesis is a complex process orchestrated by dynamic interactions between Atg (autophagy-related) proteins and characterized by the turnover of specific cargoes, which can differ over time and depending on...
8.
Muller S, Peiro-Aventin B, Biagioni G, Tini G, Saturi G, Kronberger C, et al.
Eur J Heart Fail . 2024 Jun; 26(9):2025-2034. PMID: 38887861
Aims: The 2021 European Society of Cardiology (ESC) screening recommendations for individuals carrying a pathogenic transthyretin amyloidosis variant (ATTRv) are based on expert opinion. We aimed to (i) determine the...
9.
Porcari A, Cappelli F, Nitsche C, Tomasoni D, Sinigiani G, Longhi S, et al.
J Am Coll Cardiol . 2024 Jun; 83(24):2411-2422. PMID: 38866445
Background: Transthyretin cardiomyopathy (ATTR-CM) was an exclusion criterion in randomized clinical trials of sodium-glucose cotransporter 2 inhibitors (SGLT2i). Objectives: This study sought to assess the effectiveness and tolerability of SGLT2i...
10.
Del Franco A, Biagioni G, Mazzoni C, Argiro A, Zampieri M, Cappelli F
Heart Fail Clin . 2024 Jun; 20(3):325-331. PMID: 38844303
Amyloidosis is a systemic disease due to the accumulation of misfolded amyloid fibrils that damage the heart and worsen the prognosis. Heart failure (HF), a condition frequently linked with an...